GC-1112

N/A

Report date: 2023/12/20 20:09:15

Base Information

Drug NameGC-1112
Drug Alias NameGC-1112
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesPurpura, Thrombocytopenic, Idiopathic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGC Biopharma Corp
Active IndicationsN/A
Inactive IndicationsImmunologic Deficiency SyndromesPurpura, Thrombocytopenic, Idiopathic

Other Information

ATC CodeN/A
Related LinksN/A